Why the study?
Do thrombolytic agents reduce mortality in patients with acute myocardial infarction?
Do thrombolytic agents reduce mortality in patients with acute myocardial infarction?
This early review of thrombolytic trials in acute myocardial infarction showed potential mortality benefits in general wards but conflicting results in coronary care units, highlighting the need for further study.
No takes yet. Share an insight, caveat, or question.
Early inconsistent trial data should not change practice; leaves open streptokinase's mortality benefit and requires larger randomized confirmation.
Toby L. Simon (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: